Teriparatide biosimilar (Virchow/Sun)

特立帕肽生物类似药（Virchow/Sun）

Report date: 2023/01/13 20:00:32

Base Information

Drug NameTeriparatide biosimilar (Virchow/Sun)
Drug Alias NameTeriparatide follow-on biologic (Virchow/Sun)特立帕肽生物仿制药（Virchow/Sun）recombinant parathyroid hormone 1-34BonistaOsteotide +[6] 
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionParathyroid hormone replacements
TargetsParathyroid hormone receptor
Therapy Area/IndicationsOsteoporosis, PostmenopausalOsteoporosis
Global Approved IndicationsOsteoporosis, PostmenopausalOsteoporosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved DateN/A
Country/TerritoryIndiaEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSun Pharmaceutical Industries LtdVirchow Group
China Registration ClassN/A

Develop Information

Active CompaniesSun Pharmaceutical Industries (Europe) Bv
Inactive CompaniesN/A
Active IndicationsOsteoporosis, PostmenopausalOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeH05AA02
Related LinksN/A